Challenges in Transfusion Microbiology

Barbara, 1991, Microbiology in the national blood transfusion service, 269 Barbara, 1992, Transfusion-transmitted infections; epidemiology relevant to blood safety, 1, 419 Kleinman, 1991, Donor screening procedures and their role in enhancing transfusion safety, 207 Cameron, 1980, Confirmation of specificity by neutralisation in immunoradiometric assay for hepatitis B surface antigen, J Virol Meth, 1, 113, 10.1016/0166-0934(80)90019-1 Bäcker, 1987, HIV antigen screening in blood donors, Lancet, 2, 1213, 10.1016/S0140-6736(87)91353-5 Barbara, 1991, Screening procedures for blood-borne viruses, 437 Zuck, 1987, The human immunodeficiency virus: Testing for its presence and strategies for its inactivation, 109 Genesca, 1989, What do Western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors?, Lancet, 2, 1023, 10.1016/S0140-6736(89)91027-1 van der Poel, 1989, Blood donors with indeterminate anti-p24 gag reactivity in HIV-1 Western blot: Absence of infectivity to transfused patients and in virus culture, Vox Sang, 56, 162, 10.1111/j.1423-0410.1989.tb02020.x Barbara, 1992, Hepatitis C and blood transfusion, Curr Opin Inf Dis, 5, 536, 10.1097/00001432-199208000-00007 Garson JA, Barbara JAJ: Polymerase chain reaction as a diagnostic tool in transfusion-related infections, in Anderson KC, Ness PM (eds): Scientific Basis of Transfusion Medicine. Philadelphia, PA, Saunders (in press) Follett, 1991, HCV confirmatory testing of blood donors, Lancet, 338, 1024, 10.1016/0140-6736(91)91891-W Garson, 1990, Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus contaminated factor VIII concentrates, Lancet, 336, 1022, 10.1016/0140-6736(90)92487-3 Maclennan, 1992, Screening blood donations for HCV, Lancet, 339, 131, 10.1016/0140-6736(92)91048-D Goodrick, 1992, History of previous drug misuse in HCV-positive blood donors, Lancet, 339, 502, 10.1016/0140-6736(92)91121-N Reesink, 1992, Blood donor screening or “overscreening”: How far to go in avoiding transmission of infectious agents?, Vox Sang, 63, 59, 10.1111/j.1423-0410.1992.tb01221.x LePont, 1990, Anti-HBc testing can decrease the residual risk of transfusion-related HIV transmission by more than one third, Vox Sang, 59, 248, 10.1111/j.1423-0410.1990.tb00248.x Kojima, 1991, Post transfusion fulminant hepatitis B associated with pre core-defective HBV mutants, Vox Sang, 60, 34, 10.1111/j.1423-0410.1991.tb00868.x Zangerle, 1992, Reducing HIV transmission by seronegative blood, Lancet, 339, 130, 10.1016/0140-6736(92)91046-B Contreras, 1992, Screening for HIV p24 antigen, Lancet, 339, 438, 10.1016/0140-6736(92)90134-O Grant, 1989, Transfusion associated acute Chagas’ disease acquired in the USA, Ann Intern Med, 111, 849, 10.7326/0003-4819-111-10-849 Nickerson, 1989, Transfusion-associated Trypanosoma cruzi infection in a non-endemic area, Ann Intern Med, 111, 852, 10.7326/0003-4819-111-10-851 Marcus, 1982, A case report of transfusion-induced babesiosis, JAMA, 248, 465, 10.1001/jama.248.4.465 Barbara, 1991, Screening blood donors for retroviruses, J Biomed Sci, 2, 45 Imagawa, 1991, HIV-l in seronegative homosexual men, N Engl J Med, 325, 1250, 10.1056/NEJM199110243251713 Chiewsilp, 1991, Risk of transmission of HIV by seronegative blood, Lancet, 338, 1341, 10.1016/0140-6736(91)92650-Q Puckett, 1992, Post transfusion septicaemia 1980–1989: Importance of donor arm cleansing, J Clin Pathol, 45, 155, 10.1136/jcp.45.2.155 1990, Transfusion associated Yersinia enterocolitica, Transfusion, 30, 193, 10.1046/j.1537-2995.1990.30390194335.x Nedjar, 1991, Co-amplification of specific sequences of HCV and HIV-1 genomes by using the polymerase chain reaction assay: A potential tool for the simultaneous detection of HCV and HIV-1, J Virol Meth, 35, 297, 10.1016/0166-0934(91)90071-7 1988, Blood recalled: FDA announces annual inspections, Am Assoc Blood Banks News Briefs, 11, 1 Barbara, 1989, Defining the information flow in the transfusion-microbiology laboratory, 91 Gunson, 1991, Screening of blood donations for HIV-1 antibody: 1985–1991, Communicable Dis Rep, 1, R144 Courtois, 1992, Transmission of HIV by transfusion of HIV-screened blood: The value of a national register, Transfus Med, 2, 51, 10.1111/j.1365-3148.1992.tb00134.x Barbara, 1990, The feasibility and value of long term repositories of samples from blood donations, Transfus Today, 8, 3 Cuthbertson, 1991, Viral contamination of human plasma and procedures for preventing virus transmission by plasma products, 385 Skidmore, 1990, Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis, J Med Virol, 30, 50, 10.1002/jmv.1890300111 Park, 1991, Plastic “dipstick” cuts cost of HIV testing, New Scientist March, 9, 26 Rodriguez, 1991, Anti-HIV-1: Extended validation of a modified gelatin particle agglutination assay, and its use with an image analyser, Med Lab Sci, 48, 256 1991, Recommendation for testing for HIV antibody on serum pools, WHO Wkly Epidem Rec, 44, 326